A statement by a group of international experts said that the World Health Organization does not recommend the use of the anti-viral drug “Remdisfer” to treat (Covid-19) patients, regardless of the severity of their health conditions.
The anti-viral drug “remdesivir.”
The statement, prepared by a group of experts at the World Health Organization responsible for developing the guidelines, stated that the WHO recommendations are based on a new evidence-based review comparing the effects of multiple drugs to treat “Covid-19”.
This review included data from four international studies that included more than 7,000 infected patients.
After a careful examination of all the information by the WHO expert group, which also included four patients infected with Coronavirus, a conclusion was reached that “Remdesivir does not have a significant impact on mortality or other important outcomes for patients, such as the need for mechanical ventilation or the duration of improvement. Medical “.
Based on the data currently available, the organization stressed that there is no evidence that it actually improves patients’ vital signs.
However, experts support the idea of further research with redelivering, including gathering additional data on its effect on specific groups of patients.
The Director-General of the World Health Organization, Tedros Adhnum Ghebreyesus, had previously stated that the drugs redeliver and interferon showed “weak efficacy” in treating Coronavirus patients infection.
It is worth noting that US President Donald Trump and his wife Melania were infected with Corona and announced that he had undergone treatment with the drug “Remdisfer,” which is described as an antiviral originally tested to treat hepatitis C and Ebola.